Shire Pharmaceuticals
About Shire Pharmaceuticals
There’s a simple purpose that sits at the heart of our business: to enable people with life-altering conditions to lead better lives. This means we focus on developing treatments for conditions where the impact of our medicines can make an immediate and tangible difference for patients.
Our growth strategy is to focus on developing and marketing innovative specialty medicines for symptomatic conditions to meet significant unmet patient needs. Our two strategic priorities are to drive optimum performance of our existing products, enabling access to these medicines for patients today; and building our pipeline through research and development (R&D) and business development (BD), delivering access in the future for patients We are always looking for talented people to join the Shire team.
To learn more about Shire, visit www.shire.com.
For more information on career opportunities with Shire, please visit: www.TimeToBeBrave.com .
Shire. To be as brave as the people we help.
367 articles about Shire Pharmaceuticals
-
Shire Pharmaceuticals Group plc Release: US FDA Approves Adderall XR(R) To Treat Adults
8/12/2004
-
Structural GenomiX, Inc. Acquires Anti-Cancer Agent From Shire BioChem, Inc.
7/29/2004
-
QRxPharma Pty Ltd. And Shire Laboratories Collaborate On A Novel Controlled Release Opioid Product
3/24/2004
-
Shire Acquisition Inc. Board Of Directors Announcement; Mr. Richard de Souza Has Resigned
2/12/2004
-
Shire Laboratories Brings Legal Suit Against Shire Pharmaceuticals
1/14/2004
-
Pfizer Says UK Patients Are Denied Alzheimer Drugs
1/7/2004
-
IMPAX Laboratories, Inc. Comments On Shire Laboratories' Lawsuit Related To Generic Version Of Adderall XR
12/30/2003